XASX
XRF
Market cap172mUSD
Jul 09, Last price
1.74AUD
1D
0.00%
1Q
-3.87%
Jan 2017
866.67%
IPO
659.10%
Name
XRF Scientific Ltd
Chart & Performance
P/E
23.97
P/S
4.19
EPS
0.07
Div Yield, %
2.59%
Shrs. gr., 5y
0.93%
Rev. gr., 5y
15.37%
Revenues
59m
-0.65%
Net income
10m
+16.86%
CFO
10m
+25.35%
Dividend
Sep 11, 20250.045 AUD/sh
Earnings
Aug 17, 2026
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
XRF Scientific Limited is a supplier to the scientific, analytical, construction materials, and mining sectors across Australia, Canada, and Europe. The company produces and sells precious metal items, specialized chemical compounds, and various instruments. Its operations are divided into three primary divisions: Capital Equipment, Precious Metals, and Consumables. The Capital Equipment segment is responsible for the design, manufacturing, and maintenance of automated fusion systems, high-temperature furnaces for testing and production, and general laboratory apparatus. The Precious Metals division creates products primarily for laboratory applications and the platinum alloy market. Lastly, the Consumables segment produces chemicals and other essential supplies for analytical laboratories. Established in 1972, XRF Scientific Limited has its headquarters in Osborne Park, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||